This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Oncothyreon Inc.. Active years: 2012-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2014
Title: Linda Pestano: Innovator in Cancer Immunotherapy
Introduction
Linda Pestano is a prominent inventor based in Tucson, AZ (US). She has made significant contributions to the field of cancer immunotherapy, holding 2 patents that focus on innovative vaccine formulations. Her work aims to enhance treatment options for cancer patients through advanced immunological approaches.
Latest Patents
One of her latest patents is a MUC1 based glycolipopeptide vaccine with adjuvant. This patent provides liposomal glycolipopeptidic vaccine formulations that comprise an adjuvant and an immunogen for immunotherapy and/or treatment of cancer. This innovative approach is designed to improve the efficacy of cancer treatments by harnessing the body's immune response.
Career Highlights
Linda Pestano has established herself as a key figure in her field, working with Oncothyreon Inc., a company dedicated to developing cancer therapies. Her expertise and dedication to research have positioned her as a valuable asset in the fight against cancer.
Collaborations
Throughout her career, Linda has collaborated with notable colleagues, including Scott Peterson and Jeffrey Millard. These partnerships have contributed to the advancement of her research and the development of groundbreaking therapies.
Conclusion
Linda Pestano's innovative work in cancer immunotherapy exemplifies her commitment to improving patient outcomes through scientific research. Her patents and collaborations highlight her significant role in the ongoing battle against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile